EP-1370: Stereotactic body radiotherapy in 117 oligometastatic lymph node recurrent prostate cancer patients
نویسندگان
چکیده
منابع مشابه
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
PURPOSE To assess the outcome of prostate cancer (PCa) patients diagnosed with oligometastatic disease at recurrence and treated with stereotactic body radiotherapy (SBRT). METHODS Non-castrate patients with up to 3 synchronous metastases (bone and/or lymph nodes) diagnosed on positron emission tomography - computed tomography, following biochemical recurrence after local curative treatment, ...
متن کاملStereotactic Body Radiotherapy for Lymph Node Relapse in Ovarian Cancer
Purpose: To evaluate the effectiveness and toxicity of stereotactic body radiotherapy (SBRT) for lymph node relapse in patients with ovarian cancer. Material and Methods: Between August 2008 and March 2015, 11 patients were treated with SBRT on 20 lymph nodes of previous ovarian cancer. All patients at the time of ovarian cancer diagnosis were submitted to surgery and at least one line of chemo...
متن کاملInstitutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
BACKGROUND In limited metastatic burden of disease, stereotactic body radiotherapy (SBRT) has been shown to achieve high local control rates. It has been hypothesized that SBRT may translate to a better quality of life by delaying the need for systemic chemotherapy and possibly increasing survival. There is limited published literature on the efficacy of SBRT in limited nodal metastases. The pr...
متن کاملProstate-specific antigen kinetics after hypofractionated stereotactic body radiotherapy for localized prostate cancer
Background: stereotactic body radiotherapy (SBRT) has emerged as an effective treatment for localized prostate cancer. However, prostate-specific antigen (PSA) kinetics after SBRT has not been well characterized. The objective of the current study is to analyze the rate of PSA decline and PSA nadir following hypofractonated SBRT in localized prostate cancer. Materials and Methods: From 2008...
متن کاملSalvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes.
BACKGROUND The purpose of the study was to evaluate the prostate serum antigen (PSA) response, local control, progression-free survival (PFS), and toxicity of stereotactic body radiotherapy (SBRT) for lymph node (LN) oligorecurrent prostate cancer. PATIENTS AND METHODS Between May 2012 and October 2015, 124 lesions were treated in 94 patients with a median dose of 24 Gy in 3 fractions. Sevent...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2016
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(16)32620-2